Research libraryMOLEKUL / SOURCE RECORD

Life-Threatening Anaphylaxis due to Cerebrolysin®.

Trimmel H, Tauber W, Zikeli M · 2024 · Case reports in neurological medicine; 2024

Uncontrolled human reportEnglish abstractSource linked
This is Molekul’s research summary, not the original publication. Educational information only, not medical advice. Seek qualified healthcare help for medical conditions.

Study findings

A case report documented a severe anaphylactic reaction after intravenous Cerebrolysin, supported by laboratory testing and requiring emergency treatment.

Population and setting
One 85-year-old patient after subacute stroke
Evidence type
Uncontrolled human report
Preparation
See the original report; formulation details require verification.
Source language
eng
Title source
Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.

Study limitations

  • A case report identifies a possible serious harm but cannot estimate its frequency.
  • Full methods and risk of bias have not been independently assessed.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Source access and review scope

Indexed record and available abstract checked; full text not reviewed.

Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.

Open original source or index record ↗

DOI: 10.1155/2024/2332908

Citation and original source

Original source: Trimmel H, Tauber W, Zikeli M. Life-Threatening Anaphylaxis due to Cerebrolysin®. Case reports in neurological medicine; 2024 2024.

Molekul research summary: https://molekul.io/research/cbl-update-39055722. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Editorial policy and evidence standards